Why Is Omada Health (OMDA) Stock Down -7.63% Today?
Key Takeaways
- OMDA shares fell 7.63% to $19.86, down $1.64 from the prior session's close of $21.50.
- The decline extended a multiweek pullback that has carried the stock roughly 18% below its August highs.
- Markets pointed to post–Investor Day profit-taking after long-term targets failed to sustain Thursday's early gains.
- Elevated short interest and a steady stream of disclosed insider selling weighed on sentiment.
- Broader weakness in growth-oriented digital health and healthcare technology names compounded the move.
- Traders are now watching technical support near $20 and the company's next earnings report in early November.
Opening Summary
Omada Health, Inc. (OMDA), a South San Francisco–based provider of virtual care programs for chronic conditions such as diabetes, hypertension, and musculoskeletal issues, traded sharply lower on Friday. The stock dropped 7.63% to $19.86 during the session, compared with a prior closing price of $21.50, as investors took profits following the company's first Investor Day and a broader risk-off tone pressured smaller healthcare technology names.
Post–Investor Day "Sell the News"
The most direct catalyst behind the slide was a classic "sell the news" reaction. On Thursday, OMDA held its inaugural Investor Day and unveiled updated long-term financial targets, including annual revenue growth of at least 20%, an adjusted gross margin of 80%, and an adjusted EBITDA margin of 30%. Shares initially gained on the announcement but closed well off session highs, and that momentum reversed sharply on Friday as traders locked in gains after a run that had lifted the stock more than 40% year to date.
While the guidance signaled confidence in the company's enrollment and operating leverage, some investors interpreted the disclosures as already priced in following the stock's strong second-quarter earnings beat and raised full-year outlook in early August. The lack of a fresh, near-term catalyst left the shares vulnerable to selling pressure.
Insider Selling and Elevated Short Interest
Sentiment has also been tempered by a steady cadence of insider transactions. Chief Executive Sean Duffy and other executives sold shares under pre-arranged Rule 10b5-1 trading plans in recent weeks, filings show, a pattern that can weigh on investor confidence even when the sales are part of routine equity-management programs. At the same time, OMDA carries a relatively high short interest of roughly 13% of shares, amplifying downward moves when momentum turns negative.
Sector and Macro Pressure
The decline also reflected broader market conditions. Growth-oriented digital health and healthcare technology peers have faced renewed pressure amid a risk-off tone in equities, with concerns around inflation, interest rates, and elevated energy prices weighing on smaller, higher-multiple names. OMDA, as a recently profitable but still richly valued virtual-care provider, has been particularly sensitive to shifts in risk appetite, a dynamic that contributed to the stock's decline on Friday.
Market Context and Trading Activity
The move pushed OMDA decisively below the psychologically important $20 level and beneath its 50-day moving average, which has acted as resistance during the recent pullback. The shares remain well above their 200-day average and their 52-week low of $10.28, underscoring that the long-term trend is still intact despite the near-term correction. Trading activity was elevated relative to the stock's roughly 1.2 million share average daily volume, indicating conviction behind the sell-off rather than a quiet drift lower.
What Comes Next for OMDA
Looking ahead, investors will monitor whether OMDA can stabilize above key support levels and whether the company continues to convert its expanding membership base into durable revenue and margin growth. The next earnings report is expected in early November, with analysts maintaining a broadly positive stance and a consensus "Moderate Buy" rating, though expectations have been tempered by the recent slide. Key risks include execution on new channel partnerships, ongoing insider selling, and the broader market's appetite for growth equities in an uncertain macro environment.
Trending AI Robots
For traders seeking a more systematic approach to navigating volatile markets, Tickeron's Trending AI Robots page offers a curated view of the platform's strongest-performing automated strategies. Tickeron provides hundreds of AI trading bots covering thousands of tickers, but only the top performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving users a filtered look at what is working right now. Explore the Trending AI Robots to see which strategies are currently leading.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
OMDA's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Indicator for OMDA moved out of overbought territory on August 11, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 instances where the indicator moved out of the overbought zone. In 7 of the 7 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OMDA as a result. In 13 of 16 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for OMDA turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In 6 of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
OMDA moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OMDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for OMDA crossed bullishly above the 50-day moving average on August 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +1.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where OMDA advanced for three days, in 67 of 79 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
OMDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 73 of 83 cases where OMDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. OMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.208) is normal, around the industry mean (7.129). P/E Ratio (32.090) is within average values for comparable stocks, (44.308). OMDA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.486). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (4.252) is also within normal values, averaging (5.914).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ServicestotheHealthIndustry
Advertisement